Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …

BM Demaerschalk, DO Kleindorfer, OM Adeoye… - Stroke, 2016‏ - ahajournals.org
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …

Fatigue, psychological and cognitive impairment following transient ischaemic attack and minor stroke: a systematic review

GM Moran, B Fletcher, MG Feltham… - European journal of …, 2014‏ - Wiley Online Library
Transient ischaemic attack (TIA) and minor stroke are characterized by short‐lasting
symptoms; however, anecdotal and empirical evidence suggests that these patients …

European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

E Berge, W Whiteley, H Audebert… - European stroke …, 2021‏ - journals.sagepub.com
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical …

P Khatri, DO Kleindorfer, T Devlin, RN Sawyer, M Starr… - Jama, 2018‏ - jamanetwork.com
Importance More than half of patients with acute ischemic stroke have minor neurologic
deficits (National Institutes of Health Stroke Scale [NIHSS] score of 0-5) at presentation …

Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation …

M Galovic, N Döhler, B Erdélyi-Canavese… - The Lancet …, 2018‏ - thelancet.com
Background Stroke is one of the leading causes of acquired epilepsy in adults. An
instrument to predict whether people are at high risk of develo** post-stroke seizures is …

Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke

V Zietemann, MK Georgakis, T Dondaine, C Müller… - Neurology, 2018‏ - neurology.org
Objective To examine whether the Montreal Cognitive Assessment (MoCA) administered
within 7 days after stroke predicts long-term cognitive impairment, functional impairment …

[HTML][HTML] The safety and effectiveness of the Contour Neurovascular System (Contour) for the treatment of bifurcation aneurysms: the CERUS study

T Liebig, M Killer-Oberpfalzer, G Gal, P Schramm… - …, 2022‏ - journals.lww.com
BACKGROUND: The Contour is a novel intra-aneurysmal flow disrupting device to treat
intracranial aneurysms. OBJECTIVE: To evaluate the safety and effectiveness of the Contour …

Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke

P Khatri, MR Conaway, KC Johnston… - Stroke, 2012‏ - ahajournals.org
Background and Purpose—Prior studies have shown that patients with mild ischemic stroke
have substantial disability rates at hospital discharge. We sought to determine disability …

Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation

DJ Seiffge, M Paciaroni, D Wilson, M Koga… - Annals of …, 2019‏ - Wiley Online Library
Objective We compared outcomes after treatment with direct oral anticoagulants (DOACs)
and vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and a recent cerebral …

Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer

E Grilz, O Königsbrügge, F Posch… - …, 2018‏ - pmc.ncbi.nlm.nih.gov
In contrast to venous thromboembolism, little is known about arterial thromboembolism in
patients with cancer. The aim of this study was to quantify the risk and explore clinical risk …